遺伝性遺伝子検査の世界市場レポート 2025年

遺伝性遺伝子検査の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.0％で362億3,000万米ドルに成長します。予測期間の成長は、がんの有病率の増加、遺伝性疾患の有病率の増加、診断に対する需要の増加、個別化医療の採用の増加、臨床試験数の増加に起因しています。予測期間における主な動向には、技術の進歩、全ゲノムシークエンシング、遺伝子データの統合、個別化医療、非侵襲的出生前検査などがあります。

がんの有病率の上昇は、今後数年間の遺伝性遺伝子検査市場の成長を促進すると予想されます。がんは、体の他の領域に広がる可能性のある異常な細胞増殖を特徴とする疾患群を包含します。がん患者の増加率は、人口の高齢化、ライフスタイルの変化、環境汚染物質への暴露、遺伝的素因、診断方法の進歩などの要因に関連しています。遺伝性遺伝子検査は、がんリスクを増大させる遺伝子変異を同定し、早期モニタリングや的を絞った予防活動を促進することで、がん予防において重要な役割を果たしています。例えば、政府機関であるオーストラリア保健福祉研究所によると、オーストラリアで診断されるがん患者数は、2021年の15万6,781人から2022年には16万570人に増加し、前年比で増加しています。その結果、がんの有病率の増加が遺伝性遺伝子検査市場の拡大に拍車をかけています。

遺伝性遺伝子検査業界の主要企業は、早期発見を改善し、個別化された治療オプションを提供するために、多がん多遺伝子パネルのような最先端のゲノムソリューションの開発に注力しています。これらのマルチジーン・パネルは、様々ながんにおける複数の遺伝子変異を検査し、早期診断やオーダーメイドの治療戦略をサポートします。例えば、2024年2月、米国を拠点とするがん検診・診断検査のプロバイダーであるExact Sciences Corporationは、Riskguard遺伝性がん検査を発表しました。この検査は、10種類の一般的ながんについて、簡単な血液または唾液サンプルを用いて、遺伝子特異的がんリスクと家族性がんリスクに関する個別化されたレポートを提供します。患者が自分のがんリスクを理解し、検診や治療の決定に役立て、家族関連のがんリスクを評価するのに役立ちます。さらに、実用的な遺伝子変異を同定することで、がん患者の治療を調整し、がんの家族歴のある人のリスク評価を改善するのに役立ちます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界遺伝性遺伝子検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の遺伝性遺伝子検査市場：成長率分析
• 世界の遺伝性遺伝子検査市場の実績：規模と成長, 2019-2024
• 世界の遺伝性遺伝子検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界遺伝性遺伝子検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の遺伝性遺伝子検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 予測的および発症前検査
• キャリアテスト
• 出生前検査および新生児検査
• 診断検査
• 薬理ゲノム検査
• その他のタイプ
• 世界の遺伝性遺伝子検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞遺伝学的検査
• 生化学検査
• 分子検査
• 世界の遺伝性遺伝子検査市場臨床応用による、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん遺伝子検査
• 心血管遺伝子検査
• 神経学的遺伝子検査
• 希少疾患の遺伝子検査
• 世界の遺伝性遺伝子検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断検査室
• 調査機関
• 消費者向け（DTC）遺伝子検査会社
• 世界の遺伝性遺伝子検査市場、タイプ別予測検査および前兆検査のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疾患リスク予測のための遺伝子検査
• 遺伝性がんリスクの検査
• 心血管疾患リスク検査
• 神経変性疾患リスク検査
• 世界の遺伝性遺伝子検査市場キャリアテストの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝性疾患の検査
• 常染色体劣性疾患の遺伝子検査
• 遺伝性疾患の保因者ステータスの検査
• 世界の遺伝性遺伝子検査市場出生前検査および新生児検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非侵襲的出生前検査（NIPT）
• 羊水穿刺および絨毛膜絨毛採取（CVS）
• 遺伝性疾患の新生児スクリーニング
• 妊娠前遺伝子スクリーニング
• 世界の遺伝性遺伝子検査市場診断検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝性疾患の疑いを確認するための遺伝子検査
• 遺伝性症候群および先天性疾患の検査
• がんおよび腫瘍プロファイリングのための診断検査
• 世界の遺伝性遺伝子検査市場、薬理ゲノム検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤反応と有効性に関する遺伝子検査
• 薬剤感受性および副作用の検査
• 個別化医療と治療の最適化
• 世界の遺伝性遺伝子検査市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 健康とライフスタイルのための遺伝子検査
• 祖先と系譜のための遺伝子検査
• 研究志向の遺伝子検査

第7章 地域別・国別分析

• 世界の遺伝性遺伝子検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の遺伝性遺伝子検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 遺伝性遺伝子検査市場：競合情勢
• 遺伝性遺伝子検査市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Quest Diagnostics Incorporated
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Hologic Inc.
• Illumina Inc.
• Qiagen N.V.
• Exact Sciences Corporation
• Fulgent Genetics Inc.
• BioReference Laboratories Inc.
• BGI Group
• Invitae Corporation
• NeoGenomics Laboratories Inc.
• andMe Inc.
• MyHeritage Ltd.
• Color Health Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 遺伝性遺伝子検査市場2029：新たな機会を提供する国
• 遺伝性遺伝子検査市場2029：新たな機会を提供するセグメント
• 遺伝性遺伝子検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hereditary genetic testing is a medical procedure that analyzes deoxyribonucleic acid (DNA) to detect inherited gene mutations that may lead to disease. It helps assess an individual's risk of developing certain genetic conditions passed down from parents to offspring. This type of testing is commonly used for conditions such as cancer, heart disease, and rare inherited disorders.

The primary types of hereditary genetic testing include predictive and presymptomatic testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and others. Predictive and presymptomatic testing identifies individuals at risk of developing specific diseases before symptoms manifest. The technologies used for testing include cytogenetic testing, biochemical testing, and molecular testing. Clinical applications encompass genetic testing for cancer, cardiovascular conditions, neurological disorders, and rare diseases. End users include hospitals and clinics, diagnostic laboratories, research institutes, and direct-to-consumer (DTC) genetic testing companies.

The hereditary genetic testing market research report is one of a series of new reports from The Business Research Company that provides hereditary genetic testing market statistics, including hereditary genetic testing industry global market size, regional shares, competitors with a hereditary genetic testing market share, detailed hereditary genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary genetic testing industry. This hereditary genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hereditary genetic testing market size has grown rapidly in recent years. It will grow from $21.47 billion in 2024 to $23.88 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to a rise in the incidence of inherited disease, growth in healthcare informatics, growth in telemedicine, growth in awareness campaigns, and a rising number of genetic testing platforms.

The hereditary genetic testing market size is expected to see rapid growth in the next few years. It will grow to $36.23 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising prevalence of genetic disorders, rising demand for diagnostics, increasing adoption of personalized medicine, and rising number of clinical trials. Major trends in the forecast period include technological advancements, whole-genome sequencing, integration of genetic data, personalized medicine, and non-invasive prenatal testing.

The rising prevalence of cancer is expected to drive the growth of the hereditary genetic testing market in the coming years. Cancer encompasses a group of diseases characterized by abnormal cell growth that can spread to other areas of the body. The increasing rate of cancer cases is linked to factors such as aging populations, lifestyle changes, exposure to environmental pollutants, genetic predispositions, and advancements in diagnostic methods. Hereditary genetic testing plays a key role in cancer prevention by identifying genetic mutations that increase cancer risk, facilitating early monitoring and targeted prevention efforts. For example, according to the Australian Institute of Health and Welfare, a government agency, the number of cancer cases diagnosed in Australia rose from 156,781 in 2021 to 160,570 in 2022, highlighting a year-over-year increase. Consequently, the growing prevalence of cancer is fueling the expansion of the hereditary genetic testing market.

Leading companies in the hereditary genetic testing industry are focusing on developing cutting-edge genomic solutions, such as multi-cancer multigene panels, to improve early detection and provide personalized treatment options. These multigene panels test for multiple genetic mutations across various cancers, supporting early diagnosis and customized treatment strategies. For instance, in February 2024, Exact Sciences Corporation, a U.S.-based provider of cancer screening and diagnostic tests, introduced the Riskguard hereditary cancer test. This test offers a personalized report on gene-specific and familial cancer risks using a simple blood or saliva sample for 10 common cancers. It helps patients understand their cancer risk, informs screening and treatment decisions, and assesses family-related cancer risks. Additionally, it aids in tailoring treatment for cancer patients and improving risk assessment for individuals with a family history of cancer by identifying actionable gene variants.

In January 2022, Exact Sciences Corp., a U.S.-based molecular diagnostics company, acquired PreventionGenetics for an undisclosed sum. This acquisition was intended to enhance Exact Sciences Corp.'s portfolio of advanced cancer diagnostics and support its entry into hereditary cancer testing. PreventionGenetics is a U.S.-based genetic testing laboratory.

Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Amgen Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, NeoGenomics Laboratories Inc., 23andMe Inc., MyHeritage Ltd., Color Health Inc., MedGenome Inc., SOPHiA GENETICS SA, Devyser AB, Mapmygenome India Ltd., Igenomix S.L.

North America was the largest region in the hereditary genetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hereditary genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hereditary genetic testing market includes revenues earned by entities by providing services such as carrier screening, prenatal testing, and newborn screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hereditary Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hereditary genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hereditary genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hereditary genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Predictive And Presymptomatic Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing; Other Types
• 2) By Technology: Cytogenetic Testing; Biochemical Testing; Molecular Testing
• 3) By Clinical Application: Cancer Genetic Testing; Cardiovascular Genetic Testing; Neurological Genetic Testing; Rare Diseases Genetic Testing
• 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Direct To Consumer (DTC) Genetic Testing Companies
• Subsegments:
• 1) By Predictive and Presymptomatic Testing: Genetic Testing For Disease Risk Prediction; Testing For Inherited Cancer Risks; Cardiovascular Disease Risk Testing; Neurodegenerative Disease Risk Testing
• 2) By Carrier Testing: Testing For Inherited Genetic Disorders; Genetic Screening For Autosomal Recessive Diseases; Testing For Carrier Status Of Inherited Conditions
• 3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT); Amniocentesis and Chorionic Villus Sampling (CVS); Newborn Screening For Genetic Disorders; Preconception Genetic Screening
• 4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders; Testing For Inherited Syndromes and Congenital Diseases; Diagnostic Testing For Cancer and Tumor Profiling
• 5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy; Testing For Drug Sensitivities and Side Effects; Personalized Medicine and Treatment Optimization
• 6) By Other Types: Genetic Testing For Wellness And Lifestyle; Genetic Testing For Ancestry And Genealogy; Research-Oriented Genetic Testing
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Amgen Inc.; Laboratory Corporation of America Holdings
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hereditary Genetic Testing Market Characteristics

3. Hereditary Genetic Testing Market Trends And Strategies

4. Hereditary Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hereditary Genetic Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hereditary Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hereditary Genetic Testing Market Growth Rate Analysis
• 5.4. Global Hereditary Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hereditary Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hereditary Genetic Testing Total Addressable Market (TAM)

6. Hereditary Genetic Testing Market Segmentation

• 6.1. Global Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive And Presymptomatic Testing
• Carrier Testing
• Prenatal And Newborn Testing
• Diagnostic Testing
• Pharmacogenomic Testing
• Other Types
• 6.2. Global Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cytogenetic Testing
• Biochemical Testing
• Molecular Testing
• 6.3. Global Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Genetic Testing
• Cardiovascular Genetic Testing
• Neurological Genetic Testing
• Rare Diseases Genetic Testing
• 6.4. Global Hereditary Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Research Institutes
• Direct To Consumer (DTC) Genetic Testing Companies
• 6.5. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Predictive and Presymptomatic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing For Disease Risk Prediction
• Testing For Inherited Cancer Risks
• Cardiovascular Disease Risk Testing
• Neurodegenerative Disease Risk Testing
• 6.6. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Testing For Inherited Genetic Disorders
• Genetic Screening For Autosomal Recessive Diseases
• Testing For Carrier Status Of Inherited Conditions
• 6.7. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Prenatal and Newborn Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Invasive Prenatal Testing (NIPT)
• Amniocentesis and Chorionic Villus Sampling (CVS)
• Newborn Screening For Genetic Disorders
• Preconception Genetic Screening
• 6.8. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing For Confirming Suspected Genetic Disorders
• Testing For Inherited Syndromes and Congenital Diseases
• Diagnostic Testing For Cancer and Tumor Profiling
• 6.9. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Pharmacogenomic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing For Drug Response And Efficacy
• Testing For Drug Sensitivities and Side Effects
• Personalized Medicine and Treatment Optimization
• 6.10. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing For Wellness And Lifestyle
• Genetic Testing For Ancestry And Genealogy
• Research-Oriented Genetic Testing

7. Hereditary Genetic Testing Market Regional And Country Analysis

• 7.1. Global Hereditary Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hereditary Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hereditary Genetic Testing Market

• 8.1. Asia-Pacific Hereditary Genetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hereditary Genetic Testing Market

• 9.1. China Hereditary Genetic Testing Market Overview
• 9.2. China Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hereditary Genetic Testing Market

• 10.1. India Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hereditary Genetic Testing Market

• 11.1. Japan Hereditary Genetic Testing Market Overview
• 11.2. Japan Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hereditary Genetic Testing Market

• 12.1. Australia Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hereditary Genetic Testing Market

• 13.1. Indonesia Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hereditary Genetic Testing Market

• 14.1. South Korea Hereditary Genetic Testing Market Overview
• 14.2. South Korea Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hereditary Genetic Testing Market

• 15.1. Western Europe Hereditary Genetic Testing Market Overview
• 15.2. Western Europe Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hereditary Genetic Testing Market

• 16.1. UK Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hereditary Genetic Testing Market

• 17.1. Germany Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hereditary Genetic Testing Market

• 18.1. France Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hereditary Genetic Testing Market

• 19.1. Italy Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hereditary Genetic Testing Market

• 20.1. Spain Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hereditary Genetic Testing Market

• 21.1. Eastern Europe Hereditary Genetic Testing Market Overview
• 21.2. Eastern Europe Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hereditary Genetic Testing Market

• 22.1. Russia Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hereditary Genetic Testing Market

• 23.1. North America Hereditary Genetic Testing Market Overview
• 23.2. North America Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hereditary Genetic Testing Market

• 24.1. USA Hereditary Genetic Testing Market Overview
• 24.2. USA Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hereditary Genetic Testing Market

• 25.1. Canada Hereditary Genetic Testing Market Overview
• 25.2. Canada Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hereditary Genetic Testing Market

• 26.1. South America Hereditary Genetic Testing Market Overview
• 26.2. South America Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hereditary Genetic Testing Market

• 27.1. Brazil Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hereditary Genetic Testing Market

• 28.1. Middle East Hereditary Genetic Testing Market Overview
• 28.2. Middle East Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hereditary Genetic Testing Market

• 29.1. Africa Hereditary Genetic Testing Market Overview
• 29.2. Africa Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hereditary Genetic Testing Market Competitive Landscape And Company Profiles

• 30.1. Hereditary Genetic Testing Market Competitive Landscape
• 30.2. Hereditary Genetic Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

31. Hereditary Genetic Testing Market Other Major And Innovative Companies

• 31.1. Quest Diagnostics Incorporated
• 31.2. Eurofins Scientific SE
• 31.3. Agilent Technologies Inc.
• 31.4. Hologic Inc.
• 31.5. Illumina Inc.
• 31.6. Qiagen N.V.
• 31.7. Exact Sciences Corporation
• 31.8. Fulgent Genetics Inc.
• 31.9. BioReference Laboratories Inc.
• 31.10. BGI Group
• 31.11. Invitae Corporation
• 31.12. NeoGenomics Laboratories Inc.
• 31.13.23andMe Inc.
• 31.14. MyHeritage Ltd.
• 31.15. Color Health Inc.

32. Global Hereditary Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hereditary Genetic Testing Market

34. Recent Developments In The Hereditary Genetic Testing Market

35. Hereditary Genetic Testing Market High Potential Countries, Segments and Strategies

• 35.1 Hereditary Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hereditary Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hereditary Genetic Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33489_Hereditary_Genetic_Testing_GMR_2025